Specific Oncolytic Adenovirus Driven by Human A33 Promoter Region for Colorectal Cancer Therapy

被引：0
|
作者：
Cafferata, Eduardo G. [1 ,2 ]
Maccio, Daniela R. [1 ]
Lopez, Maria V. [1 ]
Viale, Diego L. [1 ]
Podhajcer, Osvaldo L. [1 ]
机构：
[1] UBA, CONICET, Leloir Inst, Gene Therapy Lab, Buenos Aires, DF, Argentina
[2] CeNaGeM ANLIS Carlos G Malbran, Expt Genet Dept, Buenos Aires, DF, Argentina
来源：
MOLECULAR THERAPY | 2006年 / 13卷
关键词：
D O I：
10.1016/j.ymthe.2006.08.713
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
637
引用
收藏
页码：S245 / S245
页数：1
相关论文
共 50 条
  • [31] Modification of Oncolytic Adenovirus and Its Application in Cancer Therapy
    Liang, Yin
    He, Jian
    Zhao, Yongxiang
    DISCOVERY MEDICINE, 2020, 30 (161) : 129 - 144
  • [32] Combination therapy of telomerase-specific oncolytic adenovirus and zoledronic acid in human osteosarcoma cells
    Yamakawa, Yasuaki
    Hasei, Joe
    Tazawa, Hiroshi
    Omori, Toshinori
    Osaki, Shuhei
    Sasaki, Tsuyoshi
    Yoshida, Aki
    Kunisada, Toshiyuki
    Urata, Yasuo
    Ozaki, Toshifumi
    Fujiwara, Toshiyoshi
    CANCER RESEARCH, 2014, 74 (19)
  • [33] Cloning of carrier cells infected with oncolytic adenovirus driven by midkine promoter and biosafety studies
    Hamada, Katsuyuki
    Takagi, Soichi
    Kuboshima, Hajime
    Shimada, Hideaki
    Takagi, Kazuko
    Yasuoka, Toshiaki
    Matsubara, Keiichi
    Sassa, Yukiko
    Furuya, Tetsuya
    Suzuki, Kazuhiko
    Uchide, Tsuyoshi
    Mizutani, Tetsuya
    Tani, Kenzaburo
    Itoh, Hiroshi
    Sugiyama, Takashi
    JOURNAL OF GENE MEDICINE, 2019, 21 (2-3):
  • [34] Adenovirus Receptor Expression in Cancer and Its Multifaceted Role in Oncolytic Adenovirus Therapy
    Hensen, Lobke C. M.
    Hoeben, Rob C.
    Bots, Selas T. F.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (18) : 1 - 22
  • [35] Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: Construction and testing of a tissue-specific adenovirus vector
    Latham, JPF
    Searle, PF
    Mautner, V
    James, ND
    CANCER RESEARCH, 2000, 60 (02) : 334 - 341
  • [36] MIDKINE PROMOTER-DRIVEN ONCOLYTIC ADENOVIRUS ACHIEVES EFFECTIVE TARGETING OF HUMAN MALIGNANT MESOTHELIOMA CELLS IN VITRO AND IN VIVO
    Kubo, Shuji
    Kawasaki, Yoshiko
    Yamamoto, Hideyuki
    Tagawa, Masatoshi
    Kasahara, Noriyuki
    Okamura, Haruki
    JOURNAL OF GENE MEDICINE, 2010, 12 (12): : 1067 - 1067
  • [37] Complete regression of human malignant mesothelioma xenografts following local injection of midkine promoter-driven oncolytic adenovirus
    Kubo, Shuji
    Kawasaki, Yoshiko
    Yamaoka, Norie
    Tagawa, Masatoshi
    Kasahara, Noriyuki
    Terada, Nobuyuki
    Okamura, Haruki
    JOURNAL OF GENE MEDICINE, 2010, 12 (08): : 681 - 692
  • [38] Midkine Promoter-Driven Oncolytic Adenovirus Achieves Effective Targeting of Human Malignant Mesothelioma Cells In Vitro and In Vivo
    Kubo, Shuji
    Kawasaki, Yoshiko
    Yamamoto, Hideyuki
    Tagawa, Masatoshi
    Kasahara, Noriyuki
    Okamura, Haruki
    MOLECULAR THERAPY, 2009, 17 : S115 - S115
  • [39] Pancreatic Cancer Gene Therapy with Liposome-Processed Midkine Gene Promoter-Introduced Oncolytic Adenovirus
    Okada, Rei
    Hamada, Katsuyuki
    Yamakawa, Teruki
    Kajiwara, Youji
    Shimada, Hideaki
    MOLECULAR THERAPY, 2023, 31 (04) : 715 - 715
  • [40] KRN330, a fully human antibody against A33, in combination with irinotecan for patients with metastatic colorectal cancer (mCRC).
    Bendell, J. C.
    Marshall, J.
    Berlin, J.
    Hochster, H. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
12345